[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:stage-0-transitional-cell-carcinoma":3},{"name":4,"total":5,"trials":6,"biomarkers":15,"states":16},"Stage 0 Transitional Cell Carcinoma",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT07725796","A Phase 1 Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC",[11],"Phase 1","NOT_YET_RECRUITING","2026-08-03T01:02:43.946935Z","2026-07-30T01:46:14.449226Z",[],[]]